JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH

Similar documents
Menopause & HRT. Rosie & Alex. Image:

CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology

Assessment of Nutritional Adequacy of Perimenopausal and Menopausal Working Women of Allahabad

Menopause & HRT. Matt McKenna Elliot Davis

PERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.

06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:

Menopause management NICE Implementation

Managing menopause in Primary Care and recent advances in HRT

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research ISSN:

Post-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018

CHAPTER 5: SUMMARY AND CONCLUSION

Hormones friend or foe? Undertreatment and quality of life. No conflicts of interest to declare

Physiology of Menopause

WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation

Managing menopause in Primary Care and recent advances in HRT

PRESS RELEASE. NICE issues first guideline on menopause to stop women suffering in silence

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation

Prevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University Hospital, Ojha Campus. A Cross Sectional Study

Neuroendocrine Evaluation

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories

Individual Study Table Referring to Part of the Dossier. Volume: Page:

NAMS in the News 2016

HRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College

Research Article The Treatment with Hormone Replacement Therapy and Phytoestrogens and The Evolution of Urogenital Symptoms in Postmenopausal Women

Orals,Transdermals, and Other Estrogens in the Perimenopause

International Journal of Research and Review E-ISSN: ; P-ISSN:

Best Practice & Research Clinical Obstetrics and Gynaecology

Knowledge and Perception of Menopause and Climacteric Symptoms among a Population of Women in Enugu, South East, Nigeria

Menopause Symptoms and Management: After Breast Cancer

ARIC STUDY MANUSCRIPT PROPOSAL # 714. PC Reviewed: 03/07/00 Status: Deferred Priority: SC Reviewed: Status: Priority:

Register No: Status: Public

Before you prescribe

12 th European Congress on Menopause and Andropause

An integrative cognitive vulnerability model of menopausal hot flushes and night sweats

Menopause and HRT. John Smiddy and Alistair Ledsam

Traditional Chinese Medicine (TCM) in the Management of Menopausal Symptoms/Conditions

Study of clinical presentation in cases of Polycystic Ovarian Syndrome in rural population

Menopause: diagnosis and management NICE guideline NG23. Published November 2015

First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S.

Aromatase Inhibitors & Osteoporosis

CONSIDERATIONS FOR THE HIV POSITIVE WOMAN DURING MENOPAUSE

Role of Selective Estrogen Receptor Modulators in Menopause: A Monocentric Hospital Based Qualitative Appraisal

Endocrinology of the Female Reproductive Axis

Premature Menopause : Diagnosis and Management

Noven Enters Co-Promotion Agreement with Shionogi for Brisdelle (Paroxetine) Capsules MIAMI and NEW YORK, January 13, 2014

SPECIAL CONTRIBUTION. Executive summary: Stages of Reproductive Aging Workshop (STRAW) BACKGROUND AND SIGNIFICANCE

Menopause - a summary of management

EVALUATION OF WOMEN FOLLOWING HYSTERECTOMY WITH AND WITHOUT CONSERVATION OF OVARIES

Executive summary: Stages of Reproductive Aging Workshop (STRAW)

Assessment and Treatment of Depression in Menopause

Flavonoids. PHRI Bio-Tech Sdn All rights reserved 1

A Prospective Observational Study to Evaluate the Efficacy and Safety Profiles of Leuprorelin 3 Month Depot for the Treatment of Pelvic Endometriosis

Dr Catherine Black. Head of WOOMB NZ

HORMONE THERAPY A BALANCED VIEW?? Prof Greta Dreyer

The presentations at NAMS reference Brisdelle as LDMP (low-dose mesylate salt of paroxetine), as it was referred to in clinical development.

Assessment of women in midlife

Volume 7, Issue 1, January 2018, e-issn:

A Study of Anxiety among Hospitalized Patients of Orthopedics Ward of a Tertiary Care Hospital

Real life issues & answers: The hormonal patient Defining best practice, 5 key issues & case study

Hormone Treatments and the Risk of Breast Cancer

Orilissa (elagolix) NEW PRODUCT SLIDESHOW

Psychiatric Symptomatology in Climacterium

Natural health ingredients for women in their mid-life

JMSCR Vol 04 Issue 12 Page December 2016

OVERVIEW OF MENOPAUSE

Centre for Menstrual Cycle and Ovulation Research at Eight: 2010 CeMCOR Anniversary Celebration

Hormonal Control of Human Reproduction

Effects of Transdermal Estradiol in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial

Late Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor

Reproductive Health Policy Brief

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

Colin Beevor Matron & Clinical Nurse Specialist

HORMONES AND YOUR HEALTH Charlie Tucker Pharm. D

The Female Brain: Balancing Social Expectations with Your Own Health 10/30/12. Louann Brizendine, MD

One Day Hormone Check

The Menopause What is the menopause? Symptoms of the menopause Hormone Replacement Therapy (HRT)

AusPharm CE Hormone therapy 23/09/10. Hormone therapy

Menopause Matters. Equity Office Staff Seminar 14 November 2018

A Study of the Age of Menopause and Menopausal Symptoms among Women in a Rural Area of Tamil Nadu, India

Diagnosis and Treatment of Osteoporosis. Department of Endocrinology and Metabolism Ajou University School of Medicine.

Is Extract ERr731 from the Rheum Rhaponticum Effective in Relieving Menopausal Symptoms in Women Aged 45 to 55 Years of Age?

Psychosocial Problems In Reproductive Health Of Elders

GUIDE TO WOMEN S HEALTH

Therapeutic Cohort Results

Therapeutic Cohort Results

Leg cramps and perimenopause

The Estrogen Question

Therapeutic Cohort Results

The Better Health News2

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation

Menopause and HIV. Together, we can change the course of the HIV epidemic one woman at a time.

One Day Hormone Check

Hysterectomy with Preservation of both Ovaries does not Result in Premature Ovarian Failure

What in the HRT do we do now? Selecting, managing and maintaining patients on hormone therapy.

Late Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine

DEPRESSION; PREVALENCE OF DEPRESSION AND MENOPAUSAL SYMPTOMS AMONG MENOPAUSAL WOMEN ATTENDING TERTIARY CARE HOSPITAL, MARDAN

JMSCR Vol 06 Issue 05 Page May 2018

Transcription:

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH How to cite this article: CHOWTA N K,SEBASTIAN J,CHOWTA M N.COMPARATIVE STUDY OF MENOPAUSAL SYMPTOMS IN POST MENOPAUSAL AND PERIMENOPAUSAL WOMEN.Journal of Clinical and Diagnostic Research [serial online] 2008 August [cited: 2008 August 14]; 2: 959-962. Available from http://www.jcdr.net/back_issues.asp?issn=0973-709x&year=2008&month= August &volume=2&issue=4&page=959-962 &id=241

ORIGINAL ARTICLE Comparative Study Of Menopausal Symptoms In Post Menopausal And Perimenopausal Women CHOWTA N K*, SEBASTIAN J **, CHOWTA M N *** ABSTRACT Introduction: There is a wide variation in the frequency with which women from different ethnic groups and different socioeconomic and educational backgrounds report the occurrence of symptoms associated with their menopause. The present study is addressed to the myriad of menopausal factors that affect women s health and to compare the menopausal symptoms among the high and low socioeconomic groups. Methodology: A prospective, non- interventional study was conducted in 200 females belonging to the post menopausal and perimenopausal age groups. Subjects who had hysterectomy, oophorectomy, and those who were on hormonal replacement therapy, steroids, calcium and vitamin D supplementation were excluded from the study. Detailed history was taken down from each subject. All subjects underwent complete physical examination including height and weight check. Routine investigations were done in all subjects. ECG and X-rays of vertebra and long bones were taken whenever it was necessary. Results: Perimenopausal women reported greater number of symptoms when compared to the postmenopausal group. Vasomotor symptoms and psychological symptoms showed a higher proportion in the perimenopausal group when compared to the post menopausal group, which was statistically significant. In the perimenopausal group, 68% reported vasomotor symptoms and 29% reported psychological symptoms. In the post menopausal group, vasomotor symptoms were reported by only 16%, and another 16% reported psychological symptoms. There was no significant difference in musculoskeletal and genitourinary symptoms between the two groups. Genitourinary and psychological symptoms were common in the middle socioeconomic group when compared to the lower socioeconomic group. Vasomotor symptoms were more common in the lower socioeconomic group. Conclusion: Perimenopausal women reported a greater number of menopausal symptoms when compared to post menopausal women. Women of middle socioeconomic status had more genitourinary and psychological symptoms whereas, women of the lower socioeconomic group reported more vasomotor symptoms. Key Message: Perimenopausal women have more menopausal symptoms than post menopausal women. Key Words: Post menopausal, perimenopausal, menopausal syndrome. * Associate Professor, Department of Medicine, Kasturba Medical College, Mangalore. **Postgraduate, Department of Medicine, Kasturba Medical College, Mangalore. Associate Professor,***Associate professor, Department of Pharmacology, Kasturba Medical College, Mangalore Corresponding Author: Dr.ChowtaN.K., Email:muktachowta@yahoo.co.in Introduction Natural menopause is consistently defined in epidemiological literature as the last menstrual period observed retrospectively, as 12 consecutive months of amenorrhoea without an obvious cause. The term perimenopause includes the period immediately before the menopause, and the first year after menopause. It starts when the 959

endocrinological, biological and clinical features of approaching menopause commence[1]. The most characteristic hormonal change in the menopausal transition is a progressive, though often fluctuating rise in the level of serum FSH. The rise in LH levels tends to occur later, and is less marked. The progressive increase in the life span has resulted in an increasing number of women living long after the menopause, and developing long term consequences of menopause such as osteoporosis, psychogenic manifestations and atherosclerotic heart diseases[2]. There is a wide variation in the frequency with which women from different ethnic groups and different socioeconomic and educational backgrounds report the occurrence of symptoms associated with menopause[3]. Socioeconomic status is an important determinant of health and nutritional status, as well as morbidity and mortality. The variables that affect the socioeconomic status are different in the urban and rural population. The present study is addressed to the myriad of menopausal factors that affects women s health, and to compare the menopausal symptoms among the high and low socioeconomic groups. Methodology A prospective, non- interventional study was conducted in 200 females belonging to the post menopausal and perimenopausal age groups. Subjects who had hysterectomy, oophorectomy and those who were on hormonal replacement therapy, steroids, calcium and vitamin D supplementation were excluded from the study. Subjects who self reported 3-9 months of amenorrhoea, and those subjects without amenorrhoea but with a self report of increased irregularity, were included in the perimenopausal age group[3]. Menopause is defined as the last menstrual period observed retrospectively as 12 consecutive months of amenorrhoea without an obvious cause[2]. Detailed history was taken down from each subject. All subjects underwent complete physical examination including height and weight check. Routine investigations were done in all subjects. ECG and X-rays of vertebra and long bones were taken whenever it was necessary. The socio-economic status scale (SES scale) developed by Kuppuswamy, was used to measure the socio-economic status of individuals in an urban community. Three variables- education, occupation and income were included in the scoring system. Scores <10 was included in the lower SES, and scores from 11-25 in the middle class group. Results A total of 200 subjects were included in the study, out of which 100 belonged to the perimenopausal age group, and the other 100 belonged to the post menopausal age group. Perimenopausal women reported greater number of symptoms when compared to the postmenopausal group. Vasomotor symptoms and psychological symptoms showed a higher proportion in the perimenopausal group when compared to the post menopausal group, which was statistically significant. In the perimenopausal group, 68% reported vasomotor symptoms, and 29% reported psychological symptoms. In the post menopausal group, vasomotor symptoms were reported by only 16%, and another 16% reported psychological symptoms. There was no significant difference in the musculoskeletal and genitourinary symptoms between the two groups. Genitourinary and psychological symptoms were common in the middle socioeconomic group when compared to the lower socioeconomic group. Vasomotor symptoms were more common in the lower socioeconomic group. Vasomotor symptoms were reported by 89% in the lower socioeconomic group. There were no reports of psychological symptoms in the lower socio economic group. There was no significant difference in musculoskeletal symptoms with respect to the socioeconomic status. Genitourinary symptoms were 960

reported in 47.7% of the middle socioeconomic group, and psychological symptoms were reported in 44.6% of the middle socioeconomic group, which is statistically significant when compared to the lower socioeconomic group. Discussion The most characteristic symptoms of the menopausal syndrome are hot flushes, sleep disturbances and mood changes resulting from the hyperactivity of the mid brainhypothalamic- pituitary axis, and from changes in the central nervous system. Musculoskeletal symptoms characterized by back ache, fractures on minimal trauma, decreased height, and mobility are common due to osteoporosis. The most common symptoms observed in the present study were musculoskeletal symptoms, which were seen in 98(48%) subjects, followed by vasomotor symptoms which were seen in 84(42%) patients. Genitourinary symptoms like incontinence, frequency, urgency, difficulty in voiding etc, were seen in 52 patients, and psychological symptoms were seen in 45 patients. Lagos et al[7] showed that women of low socioeconomic status had greater prevalence of biological and psychological symptoms. Van Keep and Kellrhals demonstrated that women of the lower socioeconomic group have more severe menopausal symptoms and poorer subjective adaptation to daily life than women of the higher socioeconomic class[8]. This is in contrast to the present study, which showed a greater prevalence of musculoskeletal and psychological symptoms in the middle socioeconomic group, while vasomotor symptoms were found to be more prevalent in the lower socioeconomic group. The difference found in the study could be due to sociocultural factors that are known to modify the experience of menopause and midlife. The loss of attractiveness and youth has a negative impact on the individual s perceptions of middle age. The kind and quality of interpersonal relationships that a woman has with her family and others, influences how well she copes with midlife. An earlier study by Taylor also showed that musculoskeletal symptoms were the most prevalent complaints, followed by psychological symptoms[5]. Our study showed that perimenopausal women showed greater symptoms when compared to menopausal women. A study by Taylor also showed that menopausal symptoms peak at the perimenopausal period, followed by a decline in symptoms during the post menopausal period[5]. The specific symptoms that increased at perimenopause may be subclinical signs of underlying biological and cognitive changes due to sudden changes in ovarian hormones. In contrast to the study done by Berg et al[6], the present study showed that vasomotor symptoms were more prevalent in the perimenopausal group, while musculoskeletal symptoms were common in the post menopausal age group. References: [1] Research on menopause. Bulletin of World Health organization 1990; 34;1141-43. [2] Davey DA. The menopause and climacteric. In;Charles R Ed. Dewhurst s textbook of obstetrics and gynaecology for post graduates. 5 th ed. 1995:p609. [3] Donald J. Brambilla, Sonaja M, Kinlay M, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol. 1990; 140: 1091-96. 961

[4] Barbo DM. The physiology of menopause. Med Clin North Am 1987 Jan; 71(1): 11-20. [5] Taylor DL, Fonseka P. Symptom experience of Filipino American Mid life women. Menopause. 1999; 6: 105-14. [6] Berg JA, Goonaratna C, Wijeywordene K. Perimenopausal symptoms in Srilankan Women. Ceylon Med J 1999; 44(2):63-9. [7] Lagos X, Navarro N, Illaness. Prevalence of biological and psychological symptoms in perimenopausal women of different socio economic levels. Obstetrics and gynaecology Rev. Med Chil 1998; 126(10) 1189-94. [8] Barbara A, Schindler. Psychiatric disorders of midlife. Med Clin North Am 1987; 71(1):73-80. 962